MAPT and early-onset autosomal dominant Alzheimer disease: To test for proteins that specifically and only bind to human Tau residues 16–26 (not present in murine Tau), a column containing this peptide linked to Sepharose was used to study human brain proteins that bound to the resin from control subjects and from patients with Alzheimer disease.